MBP and myeloid sarcoma: Further as we reported previously [16], by deriving homology model for NAD 104–118 complexed with human leukocyte antigen-DR2 molecule, NAD 104–118 has the potential to induce cross-reactive T cells for human MBP 85–99, which is recognized as one of the major immunodominant epitopes in MS patients [62].